Or. Admin. Code § 845-025-7100
Current through Register Vol. 63, No. 12, December 1, 2024
Section 845-025-7100 - Cannabinoid Concentrate and Extract Labeling RequirementsPrior to a cannabinoid concentrate or extract being sold or transferred to a consumer, patient or designated primary caregiver the container holding the concentrate or extract must have a label that has the following information:
(1) Processor's business or trade name and license number;(2) Business or trade name of licensee that packaged the product, if different from the processor;(4) Product identity that correctly identifies the item as either a concentrate or extract;(5) Date the concentrate or extract was made;(6) Net weight or volume in U.S. customary and metric units;(7) Serving size and number of servings per container;(8) Amount, in milligrams, of THC and CBD in each serving and in the container;(9) Activation time, expressed in words or through a pictogram;(10) Name of the lab that performed any test and any test analysis date;(12) A statement that reads: "This product is not approved by the FDA to treat, cure, or prevent any disease";(13) For cannabinoid concentrates and extracts for sale to a consumer, warnings that state: (a) "For use only by adults 21 and older. Keep out of reach of children."(b) "Do not drive a motor vehicle while under the influence of marijuana."(c) "DO NOT EAT" in bold, capital letters.(14) For medical grade cannabinoid concentrates and extracts for use by a patient, the medical grade symbol and medical warnings that state:(a) "For use by OMMP patients only. Keep out of reach of children."(b) "Do not drive a motor vehicle while under the influence of marijuana."(c) "DO NOT EAT" in bold, capital letters.Or. Admin. Code § 845-025-7100
OLCC 6-2018, adopt filed 05/23/2018, effective 6/1/2018; OLCC 152-2022, minor correction filed 03/25/2022, effective 3/25/2022Statutory/Other Authority: ORS 475C.604
Statutes/Other Implemented: ORS 475C.604